Longer wait for uterine cancer surgery reduces survival

This article originally appeared here.
Longer Wait to Surgery Worsens Survival in Uterine Cancer
Longer Wait to Surgery Worsens Survival in Uterine Cancer

(HealthDay News) -- Women who have longer wait times from diagnosis of uterine cancer to definitive surgery have reduced overall survival, according to research published online Nov. 25 in the Journal of Clinical Oncology.

Lorraine M. Elit, M.D., of McMaster University in Hamilton, Canada, and colleagues analyzed data for 9,417 women with uterine cancer to assess the effect of wait time (from histologic diagnosis to definitive surgery by hysterectomy) on all-cause survival.

The researchers found that 51.9 percent of the women had surgery by a gynecologist, and 69.9 percent had endometrioid adenocarcinoma. The five-year survival according to wait times was 71.1 percent for 0.1 to 2.0 weeks, 81.8 percent for 2.1 to 6.0 weeks, 79.5 percent for 6.1 to 12.0 weeks, and 71.9 percent for more than 12 weeks. After adjustment for other significant factors in the multivariable model, wait times of 2.0 weeks or less worsened prognosis for survival. Compared with those who had wait times between 2.1 and 12.0 weeks, patients with wait times of more than 12 weeks had worse survival.

"To the best of our knowledge, this is the first report in a large population-based cohort demonstrating that longer wait times from diagnosis of uterine cancer to definitive surgery have a negative impact on overall survival," the authors write.

Abstract
Full Text (subscription or payment may be required)

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs